Construction of an immune-related gene signature for overall survival prediction and immune infiltration in gastric cancer

Figure 5 Correlation analysis of survival time and risk scores. A: In the training cohort, there was a correlation between the patient’s risk score and gastric cancer (GC) mortality, with a higher score indicating a greater risk; B: In the test cohort, there was a correlation between the patient’s risk score and GC mortality, with a higher score indicating a greater risk; C: The scatter plot shows the correlation between survival time and risk score in GC patients in training cohort; D: The scatter plot shows the correlation between survival time and risk score in GC patients in training cohort; E: The heatmap showed that in the training cohort, LCN1, LEAP2, TMSB15A, DEFB126, PI15, IGHD3-16, IGLV3-22, CGB5, and GLP2R were highly expressed in the high-risk group, while LGR6 was highly expressed in the low-risk; F: The heatmap showed that in the test cohort, LCN1, LEAP2, TMSB15A, DEFB126, PI15, IGHD3-16, IGLV3-22, CGB5, and GLP2R were highly expressed in the high-risk group, while LGR6 was highly expressed in the low-risk.